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ABSTRACT
We studied the effects of retinoids on the in vitro survival of
melanoma colony-forming cells in biopsies obtained from ten
patients with metastatic melanoma. The results indicate that
specific retinoids reduce the ability of fresh human melanoma
cells to form colonies in soft agar. The retinoids studied had
differential effects on the survival of clonogenic melanoma
cells, and these effects vary from patient to patient. The data
provide support for the clinical trial of selected retinoids in
micrometastatic and advanced melanoma.
INTRODUCTION
Vitamin A has several important functions for normal differ
entiation of epithelial cells (6, 25, 26). Retinoids (vitamin A and
its synthetic analogs) can also prevent the development of
epithelial cancer in several organ sites in experimental animals
by modifying preneoplastic states during the latent period of
cancer development (25). Inhibitory noncytotoxic effects of ÃŸ-
all-frans-RA3 on the proliferation of murine melanoma in vitro
have been noted (13, 15). Short-term in vitro treatment of
hamster and mouse fibroblasts with retinol results in marked
changes in glycolipid synthesis patterns (1 7). These studies in
animal systems suggest that retinoids have important biochem
ical and biological effects on cells. Two years ago, our research
group reported a relatively simple soft-agar technique for direct
cultivation of human tumor stem cells from a variety of neo
plasms (8-10, 12), an approach which has recently been
confirmed by at least 3 other groups (1, 20, 29). An analysis
demonstrating applicability of the soft-agar culture system for
melanoma colony formation was recently completed (16). We
report here on the effect of retinoids on the survival of human
melanoma colonies in this clonogenic assay system.
MATERIALS AND METHODS
Retinoids. Retinol and /8-all-fraris-RA were obtained from
Sigma Chemical Co. (St. Louis, Mo.). An aromatic RA ethyl
ester analog (RO-10-9359) and 13-c/s-RA (RO-43780) were
kindly provided by E. Miller of Hoffmann-LaRoche Inc. (Nutley,
N. J.). All retinoids were suspended at 10~3 M in dimethyl
sulfoxide and kept at 4Â° in light-protected tubes until just
before use.
Patient Material. All patients (identified by code letter) had
metastatic malignant melanoma confirmed by histopathological
examination of the excised tissue studied. The 10 patients and
sites of mÃ©tastases studied were as follows: Patient A, lung;
Patient B, inguinal node; Patient C, axillary node; Patient D,
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supraclavicular node; Patient E, axillary node; Patient F, sub
cutaneous nodule; Patient G, nasal mucosa; Patient H, axillary
node; Patient I, inguinal node; and Patient J, skin nodule. This
protocol has been approved by the University of Arizona Com
mittee for the Protection of Human Subjects.
Cell Culture Techniques. Excisional biopsies of malignant
melanoma were mechanically dissociated into a single-cell
suspension and processed as described elsewhere (9, 16).
Retinoid sensitivity was assessed with the same basic assay
approach which our laboratory has previously applied for mea
surement of tumor stem cell sensitivity to cytotoxic anticancer
drugs (24). The melanoma cell suspension was incubated with
either 1.0 x 10~5 M or various concentrations of the appropri
ate retinoid at 37Â°for 1 hr. The cells were then washed twice
with serum-free medium, and 5.0 x 105 cells were mixed in a
1.0-ml volume of 0.3% agar containing 10% heat-inactivated
horse serum in enriched Connaught Medical Research Labo
ratories Medium 1066 and plated over a 1.0-ml nutrient feeder
layer of 0.50% agar in 35-mm plastic Petri dishes. Conditioned
medium was not required in the feeder layer.
Plates were incubated at 37Â° in a humidified atmosphere
containing 6% CO2 for 10 to 21 days. Melanoma colonies were
counted when they reached the 30-cell stage, generally about
14 days. All control and drug assays were done in triplicate.
Melanoma colonies from these patients all expressed melanin
pigmentation, which served as a marker of neoplastic origin of
the colony-forming cells (16). Morphology of the neoplastic
melanoma cell colonies was further defined with our new dried-
slide technique and a combination of Papanicolaou's and Lil-
lie's melanin staining (23).
RESULTS
The effects of the retinoids on melanoma colony formation
varied with the patient and the type of retinoid. Marked inhibi
tion of melanoma colony formation was noted in some patients
with different retinoids, but in no instance was survival of
melanoma colony-forming cells reduced to less than 20% of
the control. The effect of the different retinoids varied from
patient to patient. Dose-response curves for patients A through
E are presented in Chart 1.Results for 10 Patients Tested at 10"5 M Concentration of
Specific Retinoids. The effect of a single concentration of
retinoid on colony formation was tested on cells obtained by
biopsies from 10 patients with melanoma (Table 1). This con
centration was selected because it is considered to be phar
macologically achievable. Although the mean inhibition by ret
inol was 49%, the effects on survival of colony formation
ranged from 80% inhibition to mild stimulation in one case.
Similar results were seen with the other 3 retinoids tested.
Effects of Retinoids on Human Melanoma Colony Forma
tion: Dose-Response Curves. Retinol was tested in 2 patients,
and survival of melanoma colony formation was reduced 70%(A) and 80% (E) at a concentration of 10~9 M, but a further
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Molarity of Retinola (10-N)
Chart I. Effect of retinÃ³lason human melanoma colony formation. â€¢.cis-RA
(RO-43780); O. /i-all-frans-RA; A. aromatic RA ethyl ester analog (R-10-9359);
and A. retino!.
decrease in survival was not achieved at higher concentrations.
ÃŸ-AII-frans-RA was tested in 4 patients, and 3 different types
of dose-response curves were observed over the dose range
tested. In 2 patients, survival of melanoma colonies was reduced at a concentration of 10~9 M (Patient A, 30%; Patient D,
60%), but a plateau occurred where no further decrease in
survival was achieved at higher concentrations. In one patient
(Patient C), a dose-dependent effect was evident, and survival
of melanoma colonies was reduced 60% at the highest con
centration (10~5 M) used. In Patient D, a dose dependence at
lower concentrations and plateau at a higher concentration
was evident.
13-c/s-RA was tested in all 5 patients, and 3 different types
of survival curves were seen. In 3 patients (Patient A, B, and
C), no reduction (20%) in survival was observed. In one patient
(Patient E), no reduction in survival was seen except at thehighest concentration tested (10~5 M, 40% reduction in sur
vival). However, in one patient (Patient D), survival was reduced
at 10~9 M, but survival was not further reduced at higher
concentrations.
Aromatic RA ethyl ester analog was tested in 5 patients, and
2 different types of effects on melanoma colony formation were
seen. In 2 patients (Patients B and C), no response was seen.
In 3 patients, melanoma colony survival was reduced at low
concentrations, but survival was not further reduced at higher
concentrations (Patient A, 30 to 40% decrease; Patient D, 30
to 50% decrease; Patient E, 75 to 80% decrease).
Thus, in the multiple concentrations studied, 4 different types
of general responses were noted: no response at any concen
tration; a response only at high concentrations; a concentration
dose-dependent effect; and a response at low concentrations
with no further reduction in tumor colony formation with in
creasing molarity of the retinoid. Additionally, the specific
retinoid causing one or more of these responses varied from
patient to patient.
DISCUSSION
The studies reported here indicate that retinoids can reduce
the ability of fresh human melanoma cells to form colonies in
soft agar and that differential sensitivities are expressed. This
observation indicates that melanoma colony formation is het
erogeneous with respect to responsiveness to retinoids.
Whether these effects on the cells capable of forming mela
noma colonies are working through the same or different
mechanisms, or on different groups of cells has yet to be
established. We have yet to study effects of combinations of
these agents, which may partially answer this question.
Table 1
Percentage of survival of human melanoma colony formation after retinoidexposure at IO"5 M"
RetinolaPatientABCDEFGH1JMean
survivalRetinol33414620453813351Â±3.7b1
3-c/s-RA10581882461654567
Â±2.7AII-frans-RA60354064189711361Â±3.4Aromatic
RAethyl
esteranalog80918167214664
Â± 2.6
Based on the available published data, this concentration of retinoid is .
pharmacologically achievable level (5) and produces biological effects (18).0 Mean Â±S.D.
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Retinoids are not conventionally considered to be directly
cytotoxic to normal or tumor cell populations (13, 15, 19, 25).
Either the retinoids have cytotoxic effects on a small subpop-
ulation of sensitive cells which have clonogenic properties, or
are altering some fundamental property necessary for cells to
clone in vitro. The exposure time to the retinoid is short (1 hr),
which suggests that the retinoids induce a long-standing
change in the proliferative capacity of the sensitive population
of clonogenic melanoma cells. The mechanism responsible for
this effect has yet to be established.
Changes in RNA metabolism after prolonged retinoid treat
ment have been studied in several systems (2, 27, 30). We
have recently examined the short-term (1 hr) effects of retinol,
trans-, cis-, and aromatic RA on human melanoma cell lines,
and find rapid and profound effects on labeled precursor
incorporation into RNA and protein.4 Ornithine decarboxylase,
a possible regulator of RNA metabolism, has been noted to
change rapidly in response to retinol (7) and conceivably could
be playing an important role. Alternatively, alterations in sur
face proteins induced by retinoids (17) may lead to changes in
cloning ability.
While the in vivo relevance of these observations remains to
be established, a wide variety of retinoids are known to interact
directly with diverse normal and malignant cell types (4, 19).
For example, retinoids have been noted to inhibit the growth
and development of certain transplantable tumors, including
rat chondrosarcomas (11, 28), murine mammary adenocarci-
noma (19), and murine S91 melanoma (4). Also, these agents
increase host-immune responses (4), possibly acting through
stimulation of T-killer cells (3, 14). Additionally, direct effects
of retinoids on the in vitro proliferation of murine melanoma cell
lines S91 and B16 have been noted (13, 15), which supports
our direct observations on human melanoma.
In prior studies with known cytoxic agents (e.g., melphalan,
Adriamycin), our group has reported excellent correlation be
tween in vitro sensitivity or resistance in this agar culture assay
system and clinical response in vivo (24). We have recently
made similar correlative observations in melanoma patients
with cytotoxic drugs (16, 21, 22). Therefore, the results of the
current in vitro studies showing marked inhibitory effects of
relatively low doses of selected retinoids on human melanoma
colony formation provide evidence in support of initiating clin
ical trials of selected retinoids in patients with malignant mela
noma. In view of the fact that retinoids are already on trial as
chemopreventative agents in normal subjects, their use in
patients with known diagnosed cancer in the adjuvant or met-
astatic setting appears most reasonable. Such trials would
ideally be carried out in conjunction with in vitro study, so that
retinoids which we would predict to have clinical activity in
specific patients would be selected and the predictive capabil
ity of this assay system for retinoids could be directly tested.
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